Previous Article | Next Article 
Infection and Immunity, December 2001, p. 7437-7444, Vol. 69, No. 12
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.12.7437-7444.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Cellular and Humoral Immune Responses to
Borrelia burgdorferi Antigens in Patients with
Culture-Positive Early Lyme Disease
Austin
Vaz,
Lisa
Glickstein,
Jodie A.
Field,
Gail
McHugh,
Vijay K.
Sikand,
Nitin
Damle, and
Allen
C.
Steere*
Division of Rheumatology/Immunology, New
England Medical Center, Tufts University School of Medicine,
Boston, Massachusetts 02111
Received 5 July 2001/Returned for modification 27 August
2001/Accepted 7 September 2001
We determined cellular and humoral immune responses to
Borrelia burgdorferi lysate and to recombinant flagellin
(FlaB), OspC, and OspA in acute- and convalescent-phase samples from 39 culture-positive patients with erythema migrans and in 20 healthy
control subjects. During the acute illness, a median of 4 days after
the onset of erythema migrans, 51% of the patients had proliferative
cellular responses and 72% had antibody responses to at least one of
the borrelial antigens tested. During convalescence, at the conclusion of antibiotic therapy, 64% of the patients had proliferative cellular reactivity and 95% had antibody reactivity with at least one of the
spirochetal antigens tested. In both acute- and convalescent-phase samples, cellular immune responses were found as frequently to OspA as
to OspC and FlaB. Although antibody responses were also frequently seen
to OspC and FlaB, only a few patients had marginal antibody reactivity
with OspA. The percentage of patients with proliferative responses was
similar in those with clinical evidence of localized or disseminated
infection, whereas humoral reactivity was found more often in those
with disseminated disease. We conclude that cellular and humoral
responses to B. burgdorferi antigens are often found among
patients with early Lyme disease. In contrast with the other antigens
tested, cellular but not humoral reactivity was often found with OspA.
*
Corresponding author. Mailing address: Division of
Rheumatology/Immunology, New England Medical Center #406, 750 Washington St., Boston, MA 02111. Phone: (617) 636-5951. Fax: (617)
636-4252. E-mail: asteere{at}lifespan.org.
Infection and Immunity, December 2001, p. 7437-7444, Vol. 69, No. 12
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.12.7437-7444.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Wormser, G. P., Nowakowski, J., Nadelman, R. B., Visintainer, P., Levin, A., Aguero-Rosenfeld, M. E.
(2008). Impact of Clinical Variables on Borrelia burgdorferi-Specific Antibody Seropositivity in Acute-Phase Sera from Patients in North America with Culture-Confirmed Early Lyme Disease. CVI
15: 1519-1522
[Abstract]
[Full Text]
-
Barbour, A. G., Jasinskas, A., Kayala, M. A., Davies, D. H., Steere, A. C., Baldi, P., Felgner, P. L.
(2008). A Genome-Wide Proteome Array Reveals a Limited Set of Immunogens in Natural Infections of Humans and White-Footed Mice with Borrelia burgdorferi. Infect. Immun.
76: 3374-3389
[Abstract]
[Full Text]
-
Iliopoulou, B. P., Alroy, J., Huber, B. T.
(2007). CD28 Deficiency Exacerbates Joint Inflammation upon Borrelia burgdorferi Infection, Resulting in the Development of Chronic Lyme Arthritis. J. Immunol.
179: 8076-8082
[Abstract]
[Full Text]
-
Kannian, P., Drouin, E. E., Glickstein, L., Kwok, W. W., Nepom, G. T., Steere, A. C.
(2007). Decline in the Frequencies of Borrelia burgdorferi OspA161 175-Specific T Cells after Antibiotic Therapy in HLA-DRB1*0401-Positive Patients with Antibiotic-Responsive or Antibiotic-Refractory Lyme Arthritis. J. Immunol.
179: 6336-6342
[Abstract]
[Full Text]
-
Strother, K. O., Hodzic, E., Barthold, S. W., de Silva, A. M.
(2007). Infection of Mice with Lyme Disease Spirochetes Constitutively Producing Outer Surface Proteins A and B. Infect. Immun.
75: 2786-2794
[Abstract]
[Full Text]
-
Jones, K. L., Glickstein, L. J., Damle, N., Sikand, V. K., McHugh, G., Steere, A. C.
(2006). Borrelia burgdorferi Genetic Markers and Disseminated Disease in Patients with Early Lyme Disease. J. Clin. Microbiol.
44: 4407-4413
[Abstract]
[Full Text]
-
Salazar, C. A., Rothemich, M., Drouin, E. E., Glickstein, L., Steere, A. C.
(2005). Human Lyme Arthritis and the Immunoglobulin G Antibody Response to the 37-Kilodalton Arthritis-Related Protein of Borrelia burgdorferi. Infect. Immun.
73: 2951-2957
[Abstract]
[Full Text]
-
Glickstein, L., Moore, B., Bledsoe, T., Damle, N., Sikand, V., Steere, A. C.
(2003). Inflammatory Cytokine Production Predominates in Early Lyme Disease in Patients with Erythema Migrans. Infect. Immun.
71: 6051-6053
[Abstract]
[Full Text]
-
Salazar, J. C., Pope, C. D., Sellati, T. J., Feder, H. M. Jr, Kiely, T. G., Dardick, K. R., Buckman, R. L., Moore, M. W., Caimano, M. J., Pope, J. G., Krause, P. J., Radolf, J. D.
(2003). Coevolution of Markers of Innate and Adaptive Immunity in Skin and Peripheral Blood of Patients with Erythema Migrans. J. Immunol.
171: 2660-2670
[Abstract]
[Full Text]
-
Lahdenne, P., Panelius, J., Saxen, H., Heikkila, T., Sillanpaa, H., Peltomaa, M., Arnez, M., Huppertz, H.-I., Seppala, I. J.T.
(2003). Improved serodiagnosis of erythema migrans using novel recombinant borrelial BBK32 antigens. J Med Microbiol
52: 563-567
[Abstract]
[Full Text]